Swedish CDMO Recipharm, which has a dedicated DPI manufacturing facility in the UK, has begun trading on the Stockholm stock exchange, according to NASDAQ OMX. Recipharm had announced the IPO in March 2014.
Recipharm CEO Thomas Eldered said, “Today marks the beginning of a new phase in Recipharm’s life. We welcome all our new shareholders who have demonstrated their confidence in the company and its strategy for growth. As a listed company with a new access to the capital markets, I am confident that Recipharm now will be able to even more forcefully participate in the consolidation of the CMDO market.”
Read the NASDAQ OMX press release.
Watch interview of Recipharm executives:
